Results 101 to 110 of about 41,957 (164)

Exopolysaccharide-Treated Dendritic Cells Effectively Ameliorate Acute Graft-versus-Host Disease. [PDF]

Transplant Cell Ther
Kalinina O, Minter LM, Sperling AI, Hollinger MK, Le P, Osborne BA, Zhang S, Stiff P, Knight KL.   +8 more
europepmc   +1 more source

Microbiota dictate T cell clonal selection to augment graft-versus-host disease after stem cell transplantation. [PDF]

Immunity
Yeh AC, Koyama M, Waltner OG, Minnie SA, Boiko JR, Shabaneh TB, Takahashi S, Zhang P, Ensbey KS, Schmidt CR, Legg SRW, Sekiguchi T, Nelson E, Bhise SS, Stevens AR, Goodpaster T, Chakka S, Furlan SN, Markey KA, Bleakley ME, Elson CO, Bradley PH, Hill GR.   +22 more
europepmc   +1 more source

Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant: An Open-Label Randomized Clinical Trial.

JAMA Oncol
Huang R, Chen T, Wang S, Wang J, Su Y, Liu J, Zhang Y, Ma X, Wen Q, Kong P, Zhang C, Gao L, Zhong JF, Gao L, Zhang X.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Graft-vs.-Host Disease

Critical Reviews in Oral Biology & Medicine, 1997
Bone marrow transplantation (BMT) is the treatment of choice for many leukemias, lymphomas, bone marrow failure syndromes, and immundeficiency disorders, and is the primary and salvage therapy for many solid malignancies. With the establishment of national and international marrow banks, unrelated allogeneic BMT is being performed with increasing ...
S B, Woo, S J, Lee, M M, Schubert
openaire   +2 more sources

Hepatitic Variant of Graft-vs-Host Disease

American Journal of Clinical Pathology, 2022
Abstract Objectives Graft-vs-host disease (GVHD) of the liver is a complication of allogeneic hematopoietic stem cell transplantation with hepatitic and classic variants. We determined the percentage of hepatitic variant cases, compared clinicopathologic features of the two groups, and assessed ...
Tom Z Liang, Stephen Dong, Mike Fang, Yuna Gong, George Yaghmour, Shefali Chopra   +5 more
openaire   +2 more sources

Chronic Graft-vs-Host Disease

JAMA, 2003
ALLOGENEIC HEMATOPOIETIC cell transplantation (HCT) is a treatment used increasingly for a variety of malignant and nonmalignant diseases of the bone marrow and immune system. Although the procedure cures many patients with otherwise incurable diseases, it is often associated with serious immunological complications, particularly graft-vs-host disease (
Vikas, Bhushan, Robert H, Collins
openaire   +2 more sources

Approaches to graft‐vs‐host disease

Pediatric Transplantation, 2005
Abstract:  Graft‐vs‐host disease (GVHD) is one of the most difficult problems in stem cell transplantation. It is best considered in the context of the normal immune response. The role of the immune system is to identify and eliminate foreign antigens.
openaire   +2 more sources

Biology of Graft-vs.-Host Disease

Journal of Pediatric Hematology/Oncology, 1993
Graft-vs.-host disease (GVHD) is a major complication of allogeneic bone marrow transplantation, which is an important approach for the treatment of various diseases. In experimental animal models, lethal GVHD can be induced in major histocompatibility complex (MHC)-matched strain combinations that differ in their expression of multiple minor ...
openaire   +2 more sources

Ocular Manifestations of Graft-vs-Host Disease

Ophthalmology, 1983
In patients who have graft-vs-host disease (GVHD) after bone marrow transplantation, ocular involvement occurs in approximately 60% of cases. Among 13 such GVHD patients, the most frequent ocular manifestations included keratoconjunctivitis sicca, cicatricial lagophthalmos, and sterile conjunctivitis and uveitis.
R M, Franklin, K R, Kenyon, P J, Tutschka, R, Saral, W R, Green, G W, Santos   +5 more
openaire   +2 more sources

Syngeneic Graft-vs-Host Disease

Archives of Dermatology, 1987
Graft-vs-hostD) can be a lethal complication of bone marrow transplantation. The acute form of the disease most often occurs by day 60 after transplant and may affect any or all of three major target organs, namely, skin, liver, and gastrointestinal ointestinal tract.1y ute GVHD terized by a dermatitis that begins as a pruritic macular exanthem on the ...
openaire   +2 more sources